EZRA

8-K - Reliance Global Group, Inc. (0001812727) (Filer)

LAKEWOOD, NJ, June 03, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("we," "us," "our," the "Company" or "Reliance") today announced that it received formal notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement for continued listing on Nasdaq. As previously disclosed, on December 12, 2025, the Company was notified by Nasdaq that its common stock had failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. Nasdaq has now determined that the closing bid price of the Company's common st

LAKEWOOD, NJ, June 01, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("we," "us," "our," the "Company" or "Reliance") today provided an update on ENQUANTUM Ltd. ("ENQUANTUM"), its post-quantum cybersecurity investment, highlighting a significant technical milestone as global urgency around quantum-resilient cybersecurity continues to accelerate. Nation-state-level quantum computers are expected to eventually compromise many widely deployed encryption methods currently used across global digital infrastructure. ENQUANTUM is developing post-quantum security technologies designed to address this transition by integrating next-generation encryption methods, into high-perf

LAKEWOOD, NJ, May 18, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("we," "us," "our," the "Company" or "Reliance") today announced that Enquantum Ltd. ("Enquantum"), a developer of advanced networking and post-quantum cybersecurity technologies and a strategic platform investment under EZRA International Group's Scale51 initiative, successfully completed a real-world private 5G deployment with a leading Israeli construction company. The deployment demonstrated advanced worker safety, real-time operational monitoring, and intelligent site management capabilities in active construction environments. As part of the pilot program, construction workers utilized 5G-connect

8-K - Reliance Global Group, Inc. (0001812727) (Filer)

LAKEWOOD, NJ, May 14, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("Reliance", "we" or the "Company") today announced that the Company's Board of Directors approved a 1-for-40 reverse stock split (the "Reverse Stock Split") of the Company's common stock (the "Common Stock") in order to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (Rule 5550(a)(2)). The Company was not required to obtain shareholder approval to effectuate the Reverse Stock Split. The Company filed articles of amendment to the Company's articles of restatement to the articles of incorporation with the Florida Department of State, Divi

10-Q - Reliance Global Group, Inc. (0001812727) (Filer)

Company Expands Ownership-Driven Investment Model While Maintaining Insurance and InsurTech Operating Foundation Company to Host Conference Call Today at 4:30 PM Eastern Time LAKEWOOD, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("we," "us," "our," the "Company" or "Reliance") today reported financial results for the three months ended March 31, 2026, and provided an update on the continued execution of its Scale51 strategy through targeted investments in technology and life sciences platforms. Key Highlights Advanced Scale51 strategy through targeted investments in technology and life sciences platforms, including continued capital deployment into

8-K - Reliance Global Group, Inc. (0001812727) (Filer)

Lakewood, NJ, May 06, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("Reliance" or the "Company"), announced today that it will host a conference call Thursday, May 7, 2026, at 4:30 PM Eastern Time to discuss financial results for the first quarter 2026 and provide a business update. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 943560. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2381/53992 or on the investor relations section of the Company's website, https://relianceglobalgroup.com/events-and-presentat

LifeSci Global Launches as Reliance's Life Sciences Platform, Partnering with Scott Korman and David Turner as Its Founding Operator-Partners to Build, Lead and Grow the Platform Korman and Turner Bring Complementary Decades of Private Equity, Capital Markets, Healthcare and Company-Building Expertise to Anchor the Platform; Innervate Provides Exposure to Estimated $250 Million Neuroblastoma Opportunity, Potential Expansion Opportunities in Additional Disease Areas and Priority Review Voucher Upside LAKEWOOD, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("we," "us," "our," the "Company" or "Reliance") today announced the formal launch of LifeSci Global

DEFA14A - Reliance Global Group, Inc. (0001812727) (Filer)

8-K - Reliance Global Group, Inc. (0001812727) (Filer)

Transaction Expands EZRA International Group's Biotech Division, LifeSci Global, Into Late-Stage Radiopharmaceutical Imaging Initial Neuroblastoma Opportunity of Approximately $250 Million, with Additional Potential Billion-Dollar Expansion Markets and Priority Review Voucher Upside LAKEWOOD, N.J., May 04, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("we," "us," "our," the "Company" or "Reliance") today announced that LifeSci Global Group LLC ("LifeSci Global"), the biotech arm of EZRA International Group, has completed a strategic investment in Innervate Radiopharmaceuticals, a developer of positron emission tomography (PET) imaging and therapeutic radiopharmaceut

424B3 - Reliance Global Group, Inc. (0001812727) (Filer)

EFFECT - Reliance Global Group, Inc. (0001812727) (Filer)

LAKEWOOD, NJ, April 28, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("we," "us," "our," the "Company" or "Reliance") today announced it has increased its ownership in Enquantum Ltd. ("Enquantum"), a developer of next-generation post-quantum cryptographic solutions. Following Enquantum's completion of defined technical and commercial milestones, the Company funded the next investment tranche, increasing its equity position in Enquantum to approximately 29%. Upon continued execution against the remaining milestone framework, Reliance expects to obtain a 51% fully diluted controlling interest in Enquantum pursuant to the Share Purchase Agreement, dated February 5, 2026,

POS AM - Reliance Global Group, Inc. (0001812727) (Filer)

8-K - Reliance Global Group, Inc. (0001812727) (Filer)

4 - Reliance Global Group, Inc. (0001812727) (Issuer)

10-K/A - Reliance Global Group, Inc. (0001812727) (Filer)

LAKEWOOD, NJ, March 25, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("we," "us," "our," the "Company" or "Reliance") today announced the launch of RELI Exchange 2.0, the next phase of its InsurTech platform for independent insurance agencies, designed to expand recruiting capacity, improve execution and position the platform for faster, more efficient growth. In February 2026, Reliance reported that health insurance policies written through RELI Exchange during the 2025 open enrollment period increased 72% year over year, Personal Lines Property and Casualty written premium increased 36% year over year, and the broker network expanded from approximately 65 to approx

4 - Reliance Global Group, Inc. (0001812727) (Issuer)

DEF 14A - Reliance Global Group, Inc. (0001812727) (Filer)

LAKEWOOD, NJ, March 19, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) ("we," "us," our," the "Company" or "Reliance") today announced that it has funded the next completed milestone in its strategic investment in Enquantum Ltd., a post-quantum cryptography company developing quantum-resilient encryption technology for high-performance environments. We believe this milestone marks a significant step forward in Enquantum's commercialization strategy under the Scale51 execution plan, highlighted by continued advancement of its core technology and R&D capabilities, positioning the company for upcoming deployment activities. Enquantum is now actively engaging with prospect